NASDAQ NMS - GLOBAL MARKET · IMDX
-0.46% · -$0.0200 · Vol 83.1K
Market closed · last close 4:00 PM ET · price as of 16:00:11 ET
Insight Molecular Diagnostics Inc

Insight Molecular Diagnostics Inc

Biotechnology
$4.32
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
IMDX
Insight Molecular Diagnostics Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

20/ 100
Veridion Score
AVOID · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IMDX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IMDX catalysts
About Insight Molecular Diagnostics Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
2015
Employees
58
Country
US

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.37
Day high
$4.46
Day low
$4.20
Previous close
$4.34
52W high
$8.48
-49.06% from high
52W low
$2.47
31% of range
Market cap
$142M
EPS
$-1.0700
Beta
3.24
Shares out
32.7M
Volume
83.1K
0.43× rel vol
Avg volume
194.4K
VWAP
$4.31
Price history computed in-house
1W
+0.93%
1M
-8.86%
3M
-32.61%
1Y
+73.49%
YTD
-42.40%
SMA 50 $4.92 · below
SMA 200 $5.38 · below
52W position 31%

IMDX overview

Veridion Score
20
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IMDX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IMDX Form 4 filings
Public disclosures

Congress activity in IMDX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IMDX in the cached public ledger.

Federal contracts

IMDX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMDX in this window.
Lobbying spend

IMDX lobbying filings, year to date.

Registered lobbying filings matched to Insight Molecular Diagnostics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMDX in this window.
Loading news for IMDX
Analyst ratings
Sovereign unlock shows live analyst consensus for IMDX.
Options
Sovereign unlock shows live options positioning for IMDX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.